BlackRock Investment Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$21.1M Buy
249,107
+41,751
+20% +$3.28M 0.02% 652
2016
Q3
$15.4M Sell
207,356
-652
-0.3% -$51.8K 0.02% 732
2016
Q2
$15.8M Sell
208,008
-213,810
-51% -$15.6M 0.02% 675
2016
Q1
$29.2M Buy
421,818
+11,712
+3% +$705K 0.04% 410
2015
Q4
$24.7M Buy
410,106
+1,240
+0.3% +$74.6K 0.03% 468
2015
Q3
$22.1M Buy
408,866
+133,094
+48% +$7.76M 0.03% 492
2015
Q2
$16M Buy
275,772
+41,487
+18% +$2.32M 0.02% 700
2015
Q1
$14.1M Buy
234,285
+3,432
+1% +$183K 0.02% 743
2014
Q4
$12.3M Sell
230,853
-1,704
-0.7% -$85.2K 0.02% 811
2014
Q3
$10.4M Buy
232,557
+672
+0.3% +$28.6K 0.01% 893
2014
Q2
$9.78M Buy
231,885
+1,902
+0.8% +$81.5K 0.01% 982
2014
Q1
$10.1M Buy
229,983
+2,203
+1% +$104K 0.01% 911
2013
Q4
$11.2M Sell
227,780
-4,460
-2% -$209K 0.02% 824
2013
Q3
$9.56M Buy
232,240
+13,322
+6% +$508K 0.02% 866
2013
Q2
$7.69M Buy
+218,918
New +$7.2M 0.01% 928

Other funds holding WST